Carl Zeiss Meditec, a subsidiary of the Carl Zeiss group that trades on the German stock exchange, has signed an agreement to take over Ioltech, a French specialist of intraocular implants and ophthalmic surgery instruments trading on the Paris Bourse, for a total of about €110 million. It will pay the equivalent of €91.80 a share in cash and shares for the French company, whose sales increased by 12.3 percent to €44.74 million in 2003. Carl Zeiss Meditec has agreed to acquire initially the 63 percent stake of Ioltech's founder, Philippe Tourrette, and to subsequently launch a tender offer for the remaining shares at the same price. Earlier this month, Carl Zeiss Meditec signed a definitive contract to acquire Laser Diagnostic Technologies (LDT), a California-based company with an annual turnover of $20 million that develops advanced systems for the detection of glaucoma.